iHuman Inc. (IH) Financial Statements
iHuman Inc. (IH) reported trailing twelve-month revenue of $752.4M (up 10.3% year on year) and net income of $24.0M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $46.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IHiHuman Inc.Follow IH — free
—
Price chart with a free account
- Market cap
- 58.3M
- P/E TTM
- —
- Dividend yield
- 9.6%
- 52-week
- —
- Next earnings
- —
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.53 | 0.94 | 0.99 | 1.02 | 0.92 | 0.81 | 0.75 | |
| Gross profit | 0.37 | 0.66 | 0.69 | 0.72 | 0.64 | 0.55 | — | |
| Research & development | 0.20 | 0.42 | 0.31 | 0.26 | 0.25 | 0.21 | — | |
| Operating income | -0.04 | -0.05 | 0.11 | 0.16 | 0.07 | 0.07 | — | |
| Pre-tax income | -0.04 | -0.04 | 0.13 | 0.20 | 0.11 | 0.10 | — | |
| Income tax | 0.00 | -0.00 | 0.02 | 0.02 | 0.01 | 0.01 | — | |
| Net income | -0.04 | -0.04 | 0.11 | 0.18 | 0.10 | 0.10 | 0.02 | |
| Diluted EPS ($) | -0.03 | -0.02 | 0.41 | 0.66 | 0.36 | 0.05 | — | |
| Diluted shares (bn) | — | 0.267 | 0.270 | 0.274 | 0.271 | 0.268 | — |
USD billions · SEC XBRL
iHuman Inc. — questions
- What is iHuman Inc.'s revenue?
- $752.4M over the twelve months to 2026-06-30, up 10.3% year on year, from its 10-Q and 10-K filings.
- What is iHuman Inc.'s net income?
- $24.0M over the twelve months to 2026-06-30.
- What is iHuman Inc.'s free cash flow?
- $46.4M over the twelve months to 2026-06-30.
Every figure on this page comes from iHuman Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.